Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk
Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk have?
Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk has 43 citations in the OpenAlex counts ScholarIQ stores.
When was Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk published?
Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk has 2019 year in the ScholarIQ index.
What is the open-access status of Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk?
Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk has closed oa status in the ScholarIQ index.
What is the DOI of Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk?
The DOI for Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk is on the source record.
What is the PMID of Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk?
The PMID for Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk is on the source record.
What is the OpenAlex record for Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk?
The OpenAlex for Use of Dual X‐ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia‐associated mortality risk is on the source record.